These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 17558182

  • 1. Effects of combined oleoyl-estrone and rimonabant on overweight rats.
    Ferrer-Lorente R, Cabot C, Fernández-López JA, Alemany M.
    J Pharmacol Sci; 2007 Jun; 104(2):176-82. PubMed ID: 17558182
    [Abstract] [Full Text] [Related]

  • 2. Combined effects of oleoyl-estrone and a beta3-adrenergic agonist (CL316,243) on lipid stores of diet-induced overweight male Wistar rats.
    Ferrer-Lorente R, Cabot C, Fernández-López JA, Alemany M.
    Life Sci; 2005 Sep 02; 77(16):2051-8. PubMed ID: 15935402
    [Abstract] [Full Text] [Related]

  • 3. Corticosterone inhibits the lipid-mobilizing effects of oleoyl-estrone in adrenalectomized rats.
    del Mar Grasa M, Serrano M, Fernández-López JA, Alemany M.
    Endocrinology; 2007 Aug 02; 148(8):4056-63. PubMed ID: 17510239
    [Abstract] [Full Text] [Related]

  • 4. Combined effects of oral oleoyl-estrone and limited food intake on body composition of young overweight male rats.
    Romero MM, Esteve M, Alemany M.
    Int J Obes (Lond); 2006 Jul 02; 30(7):1149-56. PubMed ID: 16418752
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of the slimming agent oleoyl-estrone in liposomes on the body weight of Zucker obese rats.
    Balada F, Sanchis D, Grasa MM, Virgili J, Estruch J, Fernández-López JA, Remesar X, Alemany M.
    Int J Obes Relat Metab Disord; 1997 Sep 02; 21(9):789-95. PubMed ID: 9376892
    [Abstract] [Full Text] [Related]

  • 7. Oleoyl-estrone treatment affects the ponderostat setting differently in lean and obese Zucker rats.
    Adán C, Cabot C, Vilà R, Grasa MM, Masanés RM, Esteve M, Estruch J, Fernández-López JA, Remesar X, Alemany M.
    Int J Obes Relat Metab Disord; 1999 Apr 02; 23(4):366-73. PubMed ID: 10340814
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of oleoyl-estrone with dexfenfluramine, sibutramine or phentermine on overweight rats.
    Ferrer-Lorente R, Cabot C, Fernández-López JA, Remesar X, Alemany M.
    Eur J Pharmacol; 2005 Apr 25; 513(3):243-8. PubMed ID: 15862807
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oleoyl-oestrone inhibits lipogenic, but maintains thermogenic, gene expression of brown adipose tissue in overweight rats.
    Romero Mdel M, Fernández-López JA, Esteve M, Alemany M.
    Biosci Rep; 2009 Aug 25; 29(4):237-43. PubMed ID: 18828761
    [Abstract] [Full Text] [Related]

  • 13. Short-term oral oleoyl-estrone decreases the expression of ghrelin in the rat stomach.
    Ferrer-Lorente R, Fernández-López JA, Alemany M, Cabot C.
    Regul Pept; 2009 Jan 08; 152(1-3):79-81. PubMed ID: 18848587
    [Abstract] [Full Text] [Related]

  • 14. Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
    Patel KN, Joharapurkar AA, Patel V, Kshirsagar SG, Bahekar R, Srivastava BK, Jain MR.
    Can J Physiol Pharmacol; 2014 Dec 08; 92(12):975-83. PubMed ID: 25361428
    [Abstract] [Full Text] [Related]

  • 15. Treatment of pregnant rats with oleoyl-estrone slows down pup fat deposition after weaning.
    García-Peláez B, Vilà R, Remesar X.
    Reprod Biol Endocrinol; 2008 Jun 20; 6():23. PubMed ID: 18570654
    [Abstract] [Full Text] [Related]

  • 16. Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats.
    Herling AW, Kilp S, Elvert R, Haschke G, Kramer W.
    Endocrinology; 2008 May 20; 149(5):2557-66. PubMed ID: 18276749
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide.
    Cani PD, Montoya ML, Neyrinck AM, Delzenne NM, Lambert DM.
    Br J Nutr; 2004 Nov 20; 92(5):757-61. PubMed ID: 15533263
    [Abstract] [Full Text] [Related]

  • 19. Oleoyl-estrone.
    Remesar X, Fernández-López JA, Alemany M.
    Med Res Rev; 2012 Nov 20; 32(6):1263-91. PubMed ID: 21287573
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.